Literature DB >> 15902135

Effect of delivery route on natural history of cervical dysplasia.

Bliss E K Kaneshiro1, Jared D Acoba, Jennifer Holzman, Kelly Wachi, Michael E Carney.   

Abstract

OBJECTIVE: This study was undertaken to determine the (1) impact of delivery route on the natural history of cervical dysplasia and (2) overall regression rates of cervical dysplasia in pregnant women. STUDY
DESIGN: A retrospective analysis was performed on 705 pregnant women with abnormal Papanicolaou tests who presented for prenatal care at the Kapiolani Medical Center Women's Clinic in Honolulu, Hawaii, between 1991 and 2001. Data collection included demographics, delivery route, and cervical pathology.
RESULTS: Two hundred one patients met the inclusion criteria. Regression rates for vaginal and cesarean section groups were as follows: atypical squamous cells (64% vs 70%, P = .32), low-grade squamous intraepithelial lesion (58% vs 42%, P = .073), and high-grade squamous intraepithelial lesion (53% vs 25%, P = .44). Of the total population, 30% of lesions persisted postpartum, 58% regressed, and 12% progressed.
CONCLUSION: Mode of delivery does not influence the natural history of dysplastic lesions. Gravid and nongravid women have similar regression rates.

Entities:  

Mesh:

Year:  2005        PMID: 15902135     DOI: 10.1016/j.ajog.2004.12.078

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Characterization and clinical management of abnormal cytology findings in pregnant women: a retrospective analysis.

Authors:  Rosa Freudenreich; Martin Weiss; Tobias Engler; Felix Neis; Melanie Henes
Journal:  Arch Gynecol Obstet       Date:  2022-08-17       Impact factor: 2.493

2.  HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study.

Authors:  Emilia Moreira Jalil; Francisco Inacio Bastos; Patricia Pereira Dos Santos Melli; Geraldo Duarte; Renata Toscano Simoes; Aparecida Yulie Yamamoto; Rodrigo Augustus Amaral de Morais; Silvana Maria Quintana
Journal:  BMC Infect Dis       Date:  2013-12-01       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.